SINGULAR GENOMICS SYSTEMS IN (OMIC)

Company Profile

Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. The company is headquartered in San Diego, California and currently employs 284 full-time employees. The company went IPO on 2021-05-27. The firm has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine is comprised of chemistry, including chemical compounds, polymers, and enzymes. Its product pipeline comprises two products, which include the G4 Sequencing Platform (G4) and the PX system (the PX). The G4 platform is a benchtop genomic sequencer designed to produce fast and accurate results. The G4 is designed to target the NGS market for particular applications. The PX is its second product in development and is a multiomics platform designed to target the markets for single-cell, spatial analysis and proteomics. Its PX platform leverages its sequencing technology, applying it as an in-situ readout to look at ribonucleic acid (RNA) and proteins in single cells and tissues.

Company Info

SINGULAR GENOMICS SYSTEMS IN

3010 Science Park Road

San Diego CALIFORNIA

P: 18583337830

CEO: Andrew Spaventa

Employees: 284

Website: https://singulargenomics.com/